The U.S. Food and Drug Administration (FDA) has cleared Cairo-based Rology's teleradiology platform as a class II medical device.
The platform is an image management and processing system designed to facilitate the acquisition of DICOM images from various imaging modalities and systems. These images are then encrypted, anonymized, stored, and intelligently matched with top-tier radiologists based on their availability and subspecialty.
Rology noted that it collaborated with U.S.-based firm Innolitics to navigate and streamline the regulatory approval process.